Luke Miels is the incoming CEO of GSK, a role he will assume in January 2026 after serving as Chief Commercial Officer. An Australian national, his extensive pharmaceutical career includes senior leadership roles at AstraZeneca, Roche, and Sanofi-Aventis across Asia, Europe, and the US. He holds a BSc from Flinders University and an MBA from Macquarie University.
His career has been notably international, having lived and worked in seven different countries over 25 years. He has attributed his ability to manage such a globetrotting career to having a "very tolerant wife," offering a glimpse into the personal side of his professional journey.
In a career spanning more than 25 years, he has built significant international experience by living and working in seven different countries.
Read the full overview →Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.